JNJ(Johnson & Johnson) 的财务报表:医疗保健,综合制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2022-01-02 | FY 截至 2023-01-01 | FY 截至 2023-12-31 | FY 截至 2024-12-29 | FY 截至 2025-12-28 |
|---|---|---|---|---|---|
| 营业收入 | $78.74B | $79.99B | $85.16B | $88.82B | $94.19B |
| 毛利润 | $55.34B | $55.39B | $58.61B | $61.35B | $63.94B |
| 营业利润 | — | — | — | — | — |
| 净利润 | $20.88B | $17.94B | $35.15B | $14.07B | $26.80B |
| 经营现金流 | $23.41B | $21.19B | $22.79B | $24.27B | $24.53B |
| 自由现金流 | $19.76B | $17.18B | $18.25B | $19.84B | $19.70B |
| 摊薄每股收益 | $7.81 | $6.73 | $13.72 | $5.79 | $11.03 |